Search

everythinglearnresearchcommunity

for

Search:↓

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

The compound 4c effectively inhibits the enzyme linked to hair loss.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Compound 4 is a promising treatment for hair loss with low toxicity.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The black orchid Brasiliorchis schunkeana produces chemicals that attract certain insects and have potential antimicrobial properties.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.